Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

694 results about "Variome" patented technology

The variome is the whole set of genetic variations found in populations of species that have gone through a relatively short evolution change. For example, among humans, about 1 in every 1,200 nucleotide bases differ. However, as the human species diverged only 10,000 years ago, this variation rate is comparatively small. In practice, the variome can be the sum of the single nucleotide polymorphisms (SNPs) of the population. The Human Variome Project seeks to compile this genetic variation data worldwide. Variomics is the study of variome and a branch of bioinformatics.

Methods and compositions for detecting genetic variants using capture probes and primer extension

PCT designated stage expiredWO2025029605A1Microbiological testing/measurementVariomeBioinformatics
The present disclosure features methods, compositions, and kits for determining the location of a target nucleic acid and / or detecting the presence or absence of a genetic variant in a biological sample using an array with capture probes comprising a spatial barcode and one probe which has complementarity to the capture probe, binds to target and is extended. A second probe which binds to the extended first probe and is extended and bound to capture probe. Location and genetic variant are determined by sequencing of the extended probe.
Owner:10X GENOMICS INC

Detecting mutations and ploidy in chromosomal segments

The invention provides methods, systems, and computer readable medium for detecting ploidy of chromosome segments or entire chromosomes, for detecting single nucleotide variants and for detecting both ploidy of chromosome segments and single nucleotide variants. In some aspects, the invention provides methods, systems, and computer readable medium for detecting cancer or a chromosomal abnormality in a gestating fetus.
Owner:NATERA INC

Detecting mutations and ploidy in chromosomal segments

The invention provides methods, systems, and computer readable medium for detecting ploidy of chromosome segments or entire chromosomes, for detecting single nucleotide variants and for detecting both ploidy of chromosome segments and single nucleotide variants. In some aspects, the invention provides methods, systems, and computer readable medium for detecting cancer or a chromosomal abnormality in a gestating fetus.
Owner:NATERA INC

Base editors and uses thereof

Some aspects of this disclosure provide strategies, systems, reagents, methods, and kits that are useful for the targeted editing of nucleic acids, including editing a single site within the genome of a cell or subject, e.g., within the human genome. The disclosure provides fusion proteins of nucleic acid programmable DNA binding proteins (napDNAbp), e.g., Cas9 or variants thereof, and nucleic acid editing proteins such as cytidine deaminase domains (e.g., novel cytidine deaminases generated by ancestral sequence reconstruction), and adenosine deaminases that deaminate adenine in DNA. Aspects of the disclosure relate to fusion proteins (e.g., base editors) that have improved expression and / or localize efficiently to the nucleus. In some embodiments, base editors are codon optimized for expression in mammalian cells. In some embodiments, base editors include multiple nuclear localization sequences (e.g., bipartite NLSs), e.g., at least two NLSs. In some embodiments, methods for targeted nucleic acid editing are provided.
Owner:THE BROAD INST INC

Detecting mutations and ploidy in chromosomal segments

The invention provides methods, systems, and computer readable medium for detecting ploidy of chromosome segments or entire chromosomes, for detecting single nucleotide variants and for detecting both ploidy of chromosome segments and single nucleotide variants. In some aspects, the invention provides methods, systems, and computer readable medium for detecting cancer or a chromosomal abnormality in a gestating fetus.
Owner:NATERA INC

Detecting mutations and ploidy in chromosomal segments

The invention provides methods, systems, and computer readable medium for detecting ploidy of chromosome segments or entire chromosomes, for detecting single nucleotide variants and for detecting both ploidy of chromosome segments and single nucleotide variants. In some aspects, the invention provides methods, systems, and computer readable medium for detecting cancer or a chromosomal abnormality in a gestating fetus.
Owner:NATERA INC

Protein optimization design and screening method and device based on artificial intelligence algorithm

The invention discloses a protein optimization design and screening method and device based on an artificial intelligence algorithm, and the method takes fungal luciferase as an example, and integrates multi-dimensional bioinformatics analysis and deep learning technology to realize efficient protein engineering transformation and optimization. The method comprises the following steps: firstly, identifying a binding domain of luciferase and fluorescein by utilizing an AI-driven molecular docking simulation method, and determining a key conservative site by combining literature, evolutionary analysis and structural prediction; then, generating a protein functional domain skeleton under the constraint of a fixed site by adopting a diffusion model, and performing protein sequence prediction by utilizing a graph neural network model; and finally, scoring and screening the generated sequences to obtain high-stability candidate variants. According to the method, a conservative site dynamic fusion strategy is innovatively constructed, a fixed region is optimized through logic of structure prediction, evolution site intersection priority and literature site union set expansion, the diversity and adaptability of a protein design sequence are met, and the efficiency bottleneck of a traditional scheme is broken through.
Owner:ZHEJIANG LAB

System and Method for Geometric Compression and Persistent Memory Management of Genomic Data Using Dynamic Latent Manifolds

A system and method for processing genomic data using dynamic latent manifolds that transforms multi-modal genomic datasets into geometric representations within a curved manifold space. The system receives genomic datasets including DNA sequences, genetic variants, and expression data, then extracts biological features and assesses importance using trained neural networks. Manifold curvature values are computed based on biological significance, and genomic data is embedded as geometric structures where semantic relationships are represented through distance and curvature properties. The system generates compression pressure fields that influence processing decisions and computes optimal geodesic paths through the manifold to minimize cognitive action functionals. Adaptive compression rates are determined for different genomic regions based on geometric properties and biological importance. The manifold structure evolves through use, strengthening frequently accessed pathways while applying thermodynamic decay to unused concepts. The system supports hierarchical organization across biological scales, reversible navigation, and federated learning capabilities that enable privacy-preserving collaboration.
Owner:ATOMBEAM TECH INC

Nucleobase editors comprising geocas9 and uses thereof

Some aspects of this disclosure provide strategies, systems, reagents, methods, and kits that are useful for the targeted editing of nucleic acids or the modification of nucleic acids or proteins, including editing a single site within the genome of a cell or subject, e.g., within the human genome. In some embodiments, fusion proteins of nucleic acid programmable DNA binding proteins e.g., GeoCas9 or variants thereof, and effector domains, e.g., deaminase domains, are provided. In some embodiments, methods for targeted nucleic acid editing or protein modification are provided. In some embodiments, reagents and kits for the generation of targeted nucleic acid editing proteins, e.g., fusion proteins of a GeoCas9 and effector domains, are provided.
Owner:THE BROAD INST INC

Kit for detecting excrement DNA and bird feeding habit analysis method based on kit

The invention relates to the technical field of biology, in particular to a kit for detecting excrement DNA and a bird feeding habit analysis method based on the kit, and the method comprises the following steps: S101, extracting genome DNA in a bird excrement sample; s102, obtaining a PCR (Polymerase Chain Reaction) amplification product; s103, obtaining sequencing data; s104, obtaining sequencing data subjected to first quality control; s105, obtaining sequencing data subjected to second quality control; s106, constructing an operational classification unit or amplicon sequence variant; and S107, obtaining the feeding habit information of the birds. According to the method, the species detection rate, the species classification coverage rate and the resolution ratio are high, species of different species groups can be effectively distinguished, and the feeding habits of birds with the large food composition taxonomy span can be comprehensively analyzed.
Owner:KONGQUE (CHENGDU) TECH CO LTD

Fluorinase variant

PCT designated stageWO2025170533A1TransferasesFermentationA-siteAdenosine
There is provided a fluorinase variant thereof having at least 70% sequence identity to a sequence MSDLGX6TDDSVAQCKGLMLSICPX24VX26IX28DX30CHX33MTPX37DVVEGARYIVDLPR X52FPEGTVFATTTYPATGTX70X71RSVAX76RX78KX80AALGGARGQX90AGSGX95GX97E RAEGX103YIYIAPNNGLLTX116VIEEHGYX124EAYEVSX131TX133VIPX137X138PEPTFYSR EMVAIPSAHLAAGFPLX163X164VGRX168LX170DX172EIVRFEX179X180KX182X183X184VX186G X188X189LX191GX193X194X195X196X197DHPFGNX204WTNX208HRTDLEKAGIX219YX221TX223X 224KX226VX228DGVLX233FX235LPLX239PTFADAX246X247X248GX250PVX253YX255NSRGYLX2 62X263ARNAAX269LAYPYNLX277AGX280SVX283VTX286A (SEQ ID NO: 1), wherein X is a natural amino acid, and wherein the variant comprises one or more mutations at a site selected from the group consisting of an ion-egress site, a S-Adenosyl-L-Methionine (SAM) binding site, an ion-binding site (IBS), and a conserved site. Also disclosed are polynucleotides encoding the variants, vectors comprising the polynucleotides encoding the variants, and host cells comprising the vectors thereof. Also disclosed are Methods for producing the variants, methods of catalyzing the fluorination of a compound, uses of the fluorinase variants, and methods of treatment using the fluorinase variants thereof.
Owner:AGENCY FOR SCI TECH & RES

Linking human genes to clinical phenotypes using graph neural networks

PCT designated stage expiredWO2024249973A2BiostatisticsProteomicsClinical phenotypeGraph neural networks
This disclosure describes methods, non-transitory computer readable media, and systems that can utilize one or more machine learning models to predict relationships between human genes and phenotypes. For example, the disclosed systems can generate for human genes in relation to various clinical phenotypes. As a basis for generating such predictions, the disclosed systems can train a gene embedding neural network to determine relationships between genes and phenotypes using a two-stage training process that includes a supervised training stage and an unsupervised fine-tuning stage. In addition, the disclosed systems can utilize the gene embedding neural network to generate gene-to-phenotype scores indicating relationships between genes and phenotypes based on similarities among genes (as represented by gene embeddings). Further, the disclosed systems can utilize a diagnostic variant model to determine whether genomic samples exhibit diagnostic variants based on gene-to-phenotype scores as well as other variant-level features of the genomic samples.
Owner:ILLUMINA INC

Accelerated sequencing methods

Described herein are methods of generating a coupled sequencing read pair for a polynucleotide, and methods of analyzing the coupled sequencing read pair. The coupled sequencing read pair can be analyzed to detect polynucleotide variants, including at loci that are not directly sequenced within the coupled sequencing read pair. Other analytical methods can include using coupled sequencing read pairs to construct or validate a consensus sequence. The coupled sequencing read pair may be generated for a polynucleotide by generating sequencing data for a first region by extending a primer using labeled nucleotides; further extending the primer through a second region using nucleotides provided in a second region flow order, wherein primer extension through the second region is faster than primer extension through the first region; and generating sequencing data associated with a sequence of a third region of the polynucleotide by further extending the primer using labeled nucleotides.
Owner:ULTIMA GENOMICS INC

Region-ambiguous variant detection

Methods, systems, and apparatus, including computer programs, for region-ambiguous joint detection. The method can include actions of obtaining a plurality of haplotypes, generating a plurality of joint diplotype candidates, wherein at least two of the plurality of haplotypes are associated with a first region of a reference genome and at least two of the other haplotypes are associated with a second region of the reference genome, the plurality of joint diplotype candidates comprising multiple different copy number configurations, determining a posterior probability for each of the plurality of joint diplotype candidates, determining a preferred copy number configuration of the multiple different copy number configurations, determining a region-ambiguous quality score for the plurality of joint diplotype candidates in a given position, and determining whether a variant exists in at least one of the first or second region of the reference genome based on the determined region-ambiguous quality score.
Owner:ILLUMINA INC

Base editors and uses thereof

Some aspects of this disclosure provide strategies, systems, reagents, methods, and kits that are useful for the targeted editing of nucleic acids, including editing a single site within the genome of a cell or subject, e.g., within the human genome. The disclosure provides fusion proteins of nucleic acid programmable DNA binding proteins (napDNAbp), e.g., Cas9 or variants thereof, and nucleic acid editing proteins such as cytidine deaminase domains (e.g., novel cytidine deaminases generated by ancestral sequence reconstruction), and adenosine deaminases that deaminate adenine in DNA. Aspects of the disclosure relate to fusion proteins (e.g., base editors) that have improved expression and / or localize efficiently to the nucleus. In some embodiments, base editors are codon optimized for expression in mammalian cells. In some embodiments, base editors include multiple nuclear localization sequences (e.g., bipartite NLSs), e.g., at least two NLSs. In some embodiments, methods for targeted nucleic acid editing are provided.
Owner:THE BROAD INST INC

Computer-implemented method for identifying rare variants that cause extreme gene expression levels

The technology disclosed herein relates to reliably identifying variants that cause extreme gene expression levels. Extreme gene expression levels include expression insufficiency and expression overexpression. The variants can then be used to train an artificial intelligence-based model, thereby completing a variety of prediction tasks. One example of these predictive tasks is to produce per base resolution of chromatin sequences. Another example of the chromatin task is to produce gene expression changes caused by reliably identified variants.
Owner:ILLUMINA INC

TnpB-based genome editor

Provided herein are novel TnpB polypeptides having RNA guided endonuclease activity. Also provided herein is a gene editing system comprising the TnpB polypeptide of the invention or a disarmed variant thereof, or a fusion polypeptide comprising the same, and a method of gene editing using the TnpB polypeptide of the invention or a disarmed variant thereof, or the fusion polypeptide or the gene editing system.
Owner:BEIJING INST FOR STEM CELL & REGENERATIVE MEDICINE +1

Method and system for improving affinity of antibody based on molecular dynamics and machine learning

The invention discloses a method and a system for improving antibody affinity based on molecular dynamics and machine learning, and belongs to the technical field of computer software. According to the method, a binding site of an antibody is accurately positioned by utilizing molecular dynamics, so that an optimal amino acid mutation site is screened out, a variant library of amino acid saturation mutation is constructed at the optimal amino acid mutation site, and the change quantity (# imgabs0 # value) of binding free energy of a mutant compound is calculated to serve as an evaluation basis; training a machine learning model by taking an amino acid descriptor as a feature and a # imgabs1 # value as a label, and screening out a model with optimal prediction performance; the model is used for predicting and screening mutants with a lower # imgabs2 # value (i.e., high affinity potential). The affinity of the high-affinity 1-7 single-domain antibody obtained by the method disclosed by the invention is remarkably improved by 2.98-5.04 times, so that the practicability and the high efficiency of the method are effectively verified, and a new way is opened up for the directed evolution of the single-domain antibody.
Owner:XIDIAN UNIV

Systems and Methods for Analyzing Genetic Data for Assessment of Gene Regulatory Activity

Processes that determine transcriptional regulation from genetic sequence data are described. Generally, computational models are trained to predict transcriptional regulatory effects, which can be used in several downstream applications. Various methods further develop research tools, develop and perform diagnostics, and treat individuals based on identified variants.
Owner:THE TRUSTEES OF PRINCETON UNIV +2

High-precision base editor capable of expanding editing range and improving editing efficiency

The invention relates to the field of genetic engineering in biotechnology, in particular to a high-precision base editor capable of expanding the editing range and improving the editing efficiency. According to the editor, the Cas9 variant SpRY which is not limited by PAM and cytosine deaminase CDA1 with different truncation lengths are fused, the CDA1 delta-SpRY-BE3 high-precision editor which is wider in editing range and higher in editing efficiency is constructed, and the editor can effectively edit any cytosine on a genome while keeping high editing precision. Tests in yeast and rice cells show that compared with an existing standard editor CDA1-SpRY-BE3, the editor has the advantages that the editing efficiency is remarkably improved on multiple target spots, the application value of the editor in higher eukaryotes is proved, and a more efficient and accurate tool is provided for genetic disease treatment and crop breeding.
Owner:SANYA INSTITUTE OF NANJING AGRICULTURAL UNIVERSITY +1

Method for performing local alignment, method of variant calling, and processing device and system for facilitating variant calling

A method for performing local alignment based on a query sequence of DNA and a reference sequence of DNA includes: obtaining a bit matrix H; determining at least one diagonal based on the bit matrix H; for each of the at least one diagonal, calculating an initial score for the diagonal, determining at least one trace region, determining a sub-alignment for each of the at least one trace region, consolidating the diagonal and the sub-alignment respectively of the at least one trace region to obtain an alignment, and obtaining an alignment score based on the initial score and the partial score respectively of the sub-alignment respectively of the at least one trace region; and among each of the at least one alignment thus determined respectively for each of the at least one diagonal, reserving one of the at least one alignment that has the highest alignment score therefrom.
Owner:NAT YANG MING CHIAO TUNG UNIV

Application of cynoglossus semilaevis histone and variant small RNA thereof in cynoglossus semilaevis sex differentiation

The invention relates to application of cynoglossus semilaevis histone and variant small RNA thereof in cynoglossus semilaevis sex differentiation, and belongs to the field of molecular genetic breeding, the application method is as follows: siRNA is designed according to cynoglossus semilaevis histone H3 and variant H3.3-like thereof, and the siRNA can interfere with gene expression of the histone and the variant thereof and expression of cynoglossus semilaevis sex-related genes dmrt1, tesk1 and neurl3, so that the cynoglossus semilaevis sex differentiation is realized. The expression is obviously reduced; the invention also provides a biological preparation comprising the siRNA. The biological agent can inhibit sex differentiation of cynoglossus semilaevis and reduce generation of pseudo male fishes or male fishes.
Owner:YELLOW SEA FISHERIES RES INST CHINESE ACAD OF FISHERIES SCI

Variant classifier based on deep neural networks

We introduce a variant classifier that uses trained deep neural networks to predict whether a given variant is somatic or germline. Our model has two deep neural networks: a convolutional neural network (CNN) and a fully-connected neural network (FCNN), and two inputs: a DNA sequence with a variant and a set of metadata features correlated with the variant. The metadata features represent the variant's mutation characteristics, read mapping statistics, and occurrence frequency. The CNN processes the DNA sequence and produces an intermediate convolved feature. A feature sequence is derived by concatenating the metadata features with the intermediate convolved feature. The FCNN processes the feature sequence and produces probabilities for the variant being somatic, germline, or noise. A transfer learning strategy is used to train the model on two mutation datasets. Results establish advantages and superiority of our model over traditional classifiers.
Owner:ILLUMINA INC

Compact genome editor and base editor based on IscB system and application of compact genome editor and base editor

The invention provides a genome editor enDelIscB and a genome editor enDelIscB-T5E based on an IscB system, and further provides a base editor ICBE and a base editor IABE based on the enDelIscBD60A. According to the invention, a genome editor and a base editor which are more compact in size and higher in cleavage activity and insertion / deletion efficiency are realized by optimizing a single mutation site of the activity of a DelIscB protein cleavage plasmid, an optimized variant of the DelIscB protein and an optimized sgRNA variant of the DelIscB. According to the present invention, it is verified that the albinism model is efficiently constructed by using the enDelIscB editor and the enDelIscB-T5E editor through micro-injection of the mouse embryo, such that the enDelIscB editor and the enDelIscB-T5E editor have great potential in the field of genome editing.
Owner:INSTITUTE OF BIOPHYSICS CHINESE ACADEMY OF SCIENCES

Analyzing variant sequences using in situ or spatial assays

The present disclosure relates in some aspects to methods for analyzing target nucleic acids and their spatial locations in a biological sample. In some aspects, the presence / absence, amount, and / or identity of variant sequences (e.g., single nucleotide variations such as SNPs or point mutations) in a plurality of target nucleic acids in a cell or tissue sample are analyzed in situ in the sample or using a spatial array. Also provided are oligonucleotides, sets of oligonucleotides, compositions, and kits for use in accordance with the methods.
Owner:10X GENOMICS INC